Onyx Biotec Limited (NSE:ONYX)

Market Cap	611.96M -54.7%
Revenue (ttm)	663.87M +10.6%
Net Income	10.68M -75.8%
EPS	0.65 -81.3%
Shares Out	18.13M
PE Ratio	52.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	35,800
Open	33.75
Previous Close	33.00
Day's Range	33.75 - 33.75
52-Week Range	28.10 - 58.95
Beta	n/a
RSI	48.40
Earnings Date	May 26, 2026

About Onyx Biotec

Onyx Biotec Limited develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally. The company offers water for injections (WFI), dry powder injections, and dry powder syrup. It also exports its products. Onyx Biotec Limited was incorporated in 2005 and is based in Chandigarh, India.

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 357
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONYX

Financial Performance

In fiscal year 2025, Onyx Biotec's revenue was 619.51 million, an increase of 15.26% compared to the previous year's 537.49 million. Earnings were 49.54 million, an increase of 36.31%.